Search
Research outputs
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial [2019]
Chia Stephen K. L.; Miguel Martin; Holmes Frankie A.; Ejlertsen Bent; Delaloge Suzette; Moy Beverly; Iwata Hiroji; von Minckwitz Gunter; Mansi Janine; Barrios Carlos H;
Gnant Michael; Tomašević Zorica; Denduluri Neelima; Šeparović Robert; Kim Sung-Bae; Jakobsen Erik Hugger; Harvey Vernon; Robert Nicholas; Smith II John; Harker Graydon; Zhang Bo; Eli Lisa D; Ye Yining; Lalani Alshad S; Buyse Marc; Chan Arlene;
Cancer dormancy: time to explore its clinical relevance [2013]
Gužvić Miodrag
; Klein Christoph A.
Filteri
Po tipu
- 2